- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Elisabeth Kohoutek
News 15 results
In the News · Source: Medtech Insight
Recognition
Recognition
June 22, 2023
King & Spalding Wins Impact Case of the Year Award
Recognition
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
Events 24 results
Webinar
October 10, 2023
Key Food and Beverage Issues: Recent Developments in False Advertising Litigation in the U.S and the European Union
Conference
September 12, 2023
Talk im Turm: German Supply Chain Due Diligence Act – not relevant for real estate holders and managers?!
Speaking Engagement
September 7, 2023
Elisabeth Kohoutek to Speak at Health Insurance Hack&Con 2023
Webinar
May 10, 2023
Talk im Turm – Parallel Import: ECJ Reboxing vs. Relabeling Decision
Insights 21 results
Client Alert
June 22, 2023
EU Aims for Ban of PFAS. Now is the Time to Act.
Client Alert
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
Client Alert
Article · Source: Law360
January 19, 2023
EU Medicine Reboxing Ruling Gives Guidance To Pharma Cos.